Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Apeiron Investment Group Ltd.. Director active across 5 companies, notably ATAI Life Sciences N.V.. Cumulatively, 25 reports have been logged. Split: 19 buys · 2 sells. Total volume traded: €59.1m. Activity tracked since 22 June 2021. The latest transaction was disclosed on 18 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Apeiron Investment Group Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
700,000 shares@ US$15.0016.8% of flowCommon SharesSEC:0000899243-21-025738:0
Canonical exit: 20 Sept 2021 (T+90)
25 of 25 declarations
About Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. has filed 19 disclosures between 2021-06-24 and 2026-07-24. In this sample of recent filings, buys total EUR 52347076 and sells total EUR 3677188, mainly in ATAI Life Sciences N.V., with also transactions in Sensei Biotherapeutics, Inc., Enhanced Group Inc., BIONOMICS LTD/ADR and Alto Neuroscience, Inc.; no primary role is stated, but Enhanced Group Inc. is listed with the role of Director.